PROK
PROKIDNEY CORP.Company Information
- Company Name
- PROKIDNEY CORP.
- CIK
- CIK0001850270
- Category
- <br>Emerging growth company
- Ticker: Exchange
- PROK: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- PROK
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-04-22
- Last sale
- 2026-08-20
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 529,188
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 48,153,250
- Shares outstanding
- 186,560,999
- Ownership
- 25.81%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 18.93%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 75 | 102 | 109 | 95 | 85 | 98 | 99 | 108 | 215 | 84 | 61 | 191 | ||||||
| Marketable Securities | 107 | 123 | 161 | 176 | 210 | 231 | 259 | 299 | 217 | 245 | 302 | 205 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 190 | 235 | 281 | 300 | 324 | 360 | 396 | 430 | 450 | 340 | 374 | 406 | ||||||
| Interest Receivable | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 3 | 2 | 1 | 1 | ||||||
| Other Prepaid Expense Current | 3 | 3 | 3 | 4 | 2 | 3 | 4 | 6 | 4 | 3 | 3 | 4 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current Other | - | - | 0 | 19 | 19 | 19 | 19 | - | - | - | 0 | - | ||||||
| Other Assets Current | 1 | 2 | 3 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 56 | 54 | 51 | 48 | 44 | 43 | 42 | 39 | 43 | 42 | 42 | 43 | ||||||
| Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Assets | 249 | 293 | 336 | 352 | 372 | 406 | 441 | 475 | 499 | 388 | 421 | 452 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 2 | 3 | 1 | 2 | 2 | 3 | 4 | 3 | 3 | 3 | 5 | 4 | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Liabilities Current | 20 | 22 | 29 | 26 | 25 | 28 | 31 | 21 | 15 | 13 | 18 | 15 | ||||||
| Liabilities Current | 23 | 26 | 31 | 29 | 28 | 33 | 36 | 25 | 21 | 19 | 25 | 21 | ||||||
| Taxes Payable Current | - | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 2 | 1 | 0 | ||||||
| Accrued Income Taxes Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 26 | 30 | 35 | 33 | 33 | 36 | 39 | 31 | 27 | 25 | 29 | 24 | ||||||
| Redeemable Noncontrolling Interest Equity Other Carrying Amount | 1,106 | 1,287 | 1,312 | 1,326 | 1,342 | 1,369 | 1,397 | 1,423 | 1,445 | 1,459 | 1,495 | 1,521 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -884 | -1,024 | -1,011 | -1,008 | -1,003 | -999 | -995 | -980 | -972 | -1,096 | -1,103 | -1,093 | ||||||
| Additional Paid In Capital | 435 | 266 | 259 | 242 | 232 | 219 | 206 | 200 | 189 | 53 | 36 | 41 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -1,318 | -1,290 | -1,270 | -1,251 | -1,234 | -1,218 | -1,201 | -1,180 | -1,162 | -1,149 | -1,140 | -1,134 | ||||||
| Liabilities And Stockholders Equity | 249 | 293 | 336 | 352 | 372 | 406 | 441 | 475 | 499 | 388 | 421 | 452 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPROKIDNEY CORP. (PROK) — SEC Financial Statements & Analysis
PROKIDNEY CORP. (PROK) is a biological products, (no diagnostic substances) company, incorporated in E9. PROKIDNEY CORP. trades on Nasdaq as: PROK. PROKIDNEY CORP. (PROK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, PROKIDNEY CORP. carries a market cap of $380.58M, a P/E ratio of -2.28x, a P/B ratio of -0.43x, a P/S ratio of 465.26x, an enterprise value of $305.72M, and an EV/EBITDA multiple of -1.79x. On profitability, it posts a gross margin of 102.32%, an operating margin of -21664.55%, a net margin of -20389.36%, a Return on Equity (ROE) of 17.69%, and a Return on Assets (ROA) of -53.70%. Per share, it reports EPS of $-0.89, diluted EPS of $-0.89, free cash flow per share of $-0.86, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 55.22% year-over-year, net income growth of 706.78% year-over-year, and EPS growth of 465.34% year-over-year. On the balance sheet, it maintains a current ratio of 8.36x, a quick ratio of 8.36x, working capital of $167.06M, a debt-to-equity ratio of -0.03x, a debt ratio of 0.11, an interest coverage ratio of -9327.16x, free cash flow of $-159.73M (TTM), and net debt of $-74.87M. Figures sourced from SEC EDGAR.
- Market Cap
- $380.58M
- P/E TTM
- -2.28x
- EPS TTM
- $-0.89
- P/B TTM
- -0.43x
- ROE TTM
- 17.69%
- ROA TTM
- -53.70%
- Debt To Equity
- -0.03x
- Free Cash Flow TTM
- $-159.73M
- Net Revenue TTM Growth 1Y
- 55.22%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PROKIDNEY CORP. in?
PROKIDNEY CORP. (PROK) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does PROK trade on?
PROKIDNEY CORP. (PROK) trades on the Nasdaq.
Where is PROKIDNEY CORP. incorporated?
PROKIDNEY CORP. is incorporated in Cayman Islands.
When was PROKIDNEY CORP. (PROK)'s most recent SEC filing?
PROKIDNEY CORP. (PROK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is PROK's market cap?
PROKIDNEY CORP. (PROK) has a market capitalization of $380.58M as of 2026-06-30.
What is PROK's EPS (earnings per share)?
PROKIDNEY CORP. (PROK)'s trailing twelve month EPS is $-0.89 as of 2026-06-30.
What is PROK's ROE (return on equity)?
PROKIDNEY CORP. (PROK)'s trailing twelve month Return on Equity (ROE) is 17.69% as of 2026-06-30.
What is PROK's ROA (return on assets)?
PROKIDNEY CORP. (PROK)'s trailing twelve month Return on Assets (ROA) is -53.70% as of 2026-06-30.
What is PROK's EV/EBITDA?
PROKIDNEY CORP. (PROK)'s trailing twelve month EV/EBITDA is -1.79x as of 2026-06-30.